Exploring the Immunomodulatory Potential of Pancreatic Cancer-Derived Extracellular Vesicles through Proteomic and Functional Analyses

Anna Piro(University of Chieti-Pescara), Serena Veschi(University of Chieti-Pescara)
Cancers
May 8, 2024
10.3390/cancers16101795
Cited by 7

Related Papers

Effects of repurposed drug candidates nitroxoline and nelfinavir as single agents or in combination with erlotinib in pancreatic cancer cells
|Journal of Experimental & Clinical Cancer Research|2018|59
Integrative proteomic and functional analyses provide novel insights into the action of the repurposed drug candidate nitroxoline in AsPC-1 cells
|Scientific Reports|2020|19
Exploring the Immunomodulatory Potential of Pancreatic Cancer-Derived Extracellular Vesicles through Proteomic and Functional Analyses
|Preprints.org|2024|1